PFE.HA Pfizer Inc

Other Metals & Mining Hanover Exchange
Add to portfolio Ask AI about PFE.HA
26.64 EUR
Close of Oct 29, 2026
19.70 27.04
Market cap
-
P/E
40.4x
P/B
1.96x
ROE
5.7%
Dividend yield
-
Fundamental score
1.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is PFE.HA undervalued?

Graham number
Price26.64
Graham value14.19
Premium87.7%

PFE.HA trades 87.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pfizer Inc fundamental analysis

6 of 22 checks passed

ROE 0/2

Low return on equity (5.7%), below 10%.

ROA 0/1

Return on assets (2.4%) is below the industry median (3.1%).

Profit Consistency 2/2

Profitable for 8 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-3.6%) is not above the 5-year average (-3.6% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-3.6%) is below the industry median (4.6%).

Revenue Growth 0/2

Revenue shrank 14.8% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (71.0%), up to 100%.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is 2.9x against interest expense, below 5x.

PE vs Market 0/1

PE (40.4x) is above the market median (19.6x).

PE vs Industry 0/1

PE (40.4x) is above the industry median (18.2x).

PBV 0/1

Price to book (2.0x) is above the industry median (2.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 79.3, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (3.1%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 8 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 0/1

Payout ratio is 125.7%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Pfizer Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pfizer Inc

There is no Profile data available for PFE.HA.

Full company profile